The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality
Open Access
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (5) , 409-415
- https://doi.org/10.1111/j.1469-0691.2004.00850.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Serum Level of YKL-40 is Elevated in Patients with Streptococcus pneumoniae Bacteremia and is Associated with the Outcome of the DiseaseScandinavian Journal of Infectious Diseases, 2002
- Concurrent Upregulation of Urokinase Plasminogen Activator Receptor and CD11b during Tuberculosis and Experimental EndotoxemiaInfection and Immunity, 2001
- Microbiological and Inflammatory Factors Associated with the Development of Pneumococcal PneumoniaThe Journal of Infectious Diseases, 2001
- Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator Inhibits HIV-1 ReplicationBiochemical and Biophysical Research Communications, 2001
- Release of urokinase plasminogen activator receptor during urosepsis and endotoxemiaKidney International, 2001
- Urokinase-type Plasminogen Activator Receptor (CD87) Is a Ligand for Integrins and Mediates Cell-Cell InteractionJournal of Biological Chemistry, 2001
- YKL‐40, a Matrix Protein of Specific Granules in Neutrophils, Is Elevated in Serum of Patients with Community‐Acquired Pneumonia Requiring HospitalizationThe Journal of Infectious Diseases, 1999
- Epidemiology of invasive Streptococcus pneumoniae infections in adults in FinlandEpidemiology and Infection, 1997
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- New and Emerging Etiologies for Community-Acquired Pneumonia with Implications for TherapyMedicine, 1990